Cancer
Identification and characterization of lin-28 homolog B (LIN28B) in human hepatocellular carcinoma.
Guo Y, Chen Y, Ito H, Watanabe A, Ge X, Kodama T, Aburatani H.
Gene. 2006 Dec 15;384:51-61.
Tcl1 expression in chronic lymphocytic leukemia is regulated by miR-29 and miR-181.
Pekarsky Y, Santanam U, Cimmino A, Palamarchuk A, Efanov A, Maximov V, Volinia S, Alder H, Liu CG, Rassenti L, Calin GA, Hagan JP,
Kipps T, Croce CM.
Cancer Res. 2006 Dec 15;66(24):11590-3.
Effect of ret/PTC 1 rearrangement on transcription and post-transcriptional regulation in a papillary thyroid carcinoma model.
Cahill S, Smyth P, Finn SP, Denning K, Flavin R, O'Regan EM, Li J, Potratz A, Guenther SM, Henfrey R, O'Leary JJ, Sheils O.
Mol Cancer. 2006 Dec 11;5:70.
Activation of an oncogenic microRNA cistron by provirus integration.
Wang CL, Wang BB, Bartha G, Li L, Channa N, Klinger M, Killeen N, Wabl M.
Proc Natl Acad Sci U S A. 2006 Dec 5;103(49):18680-4.
The role of microRNAs in cancer.
Stahlhut Espinosa CE, Slack FJ.
Yale J Biol Med. 2006 Dec;79(3-4):131-40.
Cancer research with non-coding RNA.
Tomaru Y, Hayashizaki Y.
Cancer Sci. 2006 Dec;97(12):1285-90.
MicroRNA expression and function in cancer.
Garzon R, Fabbri M, Cimmino A, Calin GA, Croce CM.
Trends Mol Med. 2006 Dec;12(12):580-7.
MicroRNAs in normal and cancer cells: a new class of gene expression regulators.
Bagnyukova TV, Pogribny IP, Chekhun VF.
Exp Oncol. 2006 Dec;28(4):263-9.
Global mapping of c-Myc binding sites and target gene networks in human B cells.
Zeller KI, Zhao X, Lee CW, Chiu KP, Yao F, Yustein JT, Ooi HS, Orlov YL, Shahab A, Yong HC, Fu Y, Weng Z, Kuznetsov VA, Sung WK,
Ruan Y, Dang CV, Wei CL.
Proc Natl Acad Sci U S A. 2006 Nov 21;103(47):17834-9.
Are microRNAs located in genomic regions associated with cancer?
Lamy P, Andersen CL, Dyrskjot L, Torring N, Orntoft T, Wiuf C.
Br J Cancer. 2006 Nov 20;95(10):1415-8.
MicroRNA responses to cellular stress.
Marsit CJ, Eddy K, Kelsey KT.
Cancer Res. 2006 Nov 15;66(22):10843-8.
Synthetic microRNA designed to target glioma-associated antigen 1 transcription factor inhibits division and induces late apoptosis in
pancreatic tumor cells.
Tsuda N, Ishiyama S, Li Y, Ioannides CG, Abbruzzese JL, Chang DZ.
Clin Cancer Res. 2006 Nov 1;12(21):6557-64.
Mir-17-5p regulates breast cancer cell proliferation by inhibiting translation of AIB1 mRNA.
Hossain A, Kuo MT, Saunders GF.
Mol Cell Biol. 2006 Nov;26(21):8191-201.
The role of microRNAs in normal hematopoiesis and hematopoietic malignancies.
Kluiver J, Kroesen BJ, Poppema S, van den Berg A.
Leukemia. 2006 Nov;20(11):1931-6.
MicroRNA signatures in human cancers.
Calin GA, Croce CM.
Nat Rev Cancer. 2006 Nov;6(11):857-66.
Up-regulation of dicer, a component of the MicroRNA machinery, in prostate adenocarcinoma.
Chiosea S, Jelezcova E, Chandran U, Acquafondata M, McHale T, Sobol RW, Dhir R.
Am J Pathol. 2006 Nov;169(5):1812-20.
RNAi, microRNAs, and human disease.
Hammond SM.
Cancer Chemother Pharmacol. 2006 Nov;58 Suppl 1:s63-8.
MicroRNA in lung cancer.
Nana-Sinkam SP, Geraci MW.
J Thorac Oncol. 2006 Nov;1(9):929-31.
Downregulation of miR-122 in the rodent and human hepatocellular carcinomas.
Kutay H, Bai S, Datta J, Motiwala T, Pogribny I, Frankel W, Jacob ST, Ghoshal K.
J Cell Biochem. 2006 Oct 15;99(3):671-8.
Human microRNA clusters: genomic organization and expression profile in leukemia cell lines.
Yu J, Wang F, Yang GH, Wang FL, Ma YN, Du ZW, Zhang JW.
Biochem Biophys Res Commun. 2006 Oct 13;349(1):59-68.
The bantam microRNA is a target of the hippo tumor-suppressor pathway.
Nolo R, Morrison CM, Tao C, Zhang X, Halder G.
Curr Biol. 2006 Oct 10;16(19):1895-904.
MicroRNA expression abnormalities in pancreatic endocrine and acinar tumors are associated with distinctive pathologic features and
clinical behavior.
Roldo C, Missiaglia E, Hagan JP, Falconi M, Capelli P, Bersani S, Calin GA, Volinia S, Liu CG, Scarpa A, Croce CM.
J Clin Oncol. 2006 Oct 10;24(29):4677-84.
MicroRNAs and the hallmarks of cancer.
Dalmay T, Edwards DR.
Oncogene. 2006 Oct 9;25(46):6170-5.
miRNAs and apoptosis: RNAs to die for.
Jovanovic M, Hengartner MO.
Oncogene. 2006 Oct 9;25(46):6176-87.
A small piece in the cancer puzzle: microRNAs as tumor suppressors and oncogenes.
Kent OA, Mendell JT.
Oncogene. 2006 Oct 9;25(46):6188-96.
Tumour-related microRNAs functions in Caenorhabditis elegans.
Jannot G, Simard MJ.
Oncogene. 2006 Oct 9;25(46):6197-201.
MicroRNAs and chromosomal abnormalities in cancer cells.
Calin GA, Croce CM.
Oncogene. 2006 Oct 9;25(46):6202-10.
Viruses, microRNAs and cancer.
Pfeffer S, Voinnet O.
Oncogene. 2006 Oct 9;25(46):6211-9.
Implications of micro-RNA profiling for cancer diagnosis.
Cummins JM, Velculescu VE.
Oncogene. 2006 Oct 9;25(46):6220-7.
[MicroRNA and cancer]
Ji JL, Zhang JS.
Zhonghua Bing Li Xue Za Zhi. 2006 Oct;35(10):628-30.
MicroRNAs 143 and 145 are possible common onco-microRNAs in human cancers.
Akao Y, Nakagawa Y, Naoe T.
Oncol Rep. 2006 Oct;16(4):845-50.
Epigenetic activation of tumor suppressor microRNAs in human cancer cells.
Saito Y, Jones PA.
Cell Cycle. 2006 Oct;5(19):2220-2.
MicroRNAs: a new insight into cancer genome.
Zhang L, Coukos G.
Cell Cycle. 2006 Oct;5(19):2216-9.
MicroRNA involvement in mammary gland development and breast cancer.
Silveri L, Tilly G, Vilotte JL, Le Provost F.
Reprod Nutr Dev. 2006 Sep-Oct;46(5):549-56.
Inhibition of PRL-3 gene expression in gastric cancer cell line SGC7901 via microRNA suppressed reduces peritoneal metastasis.
Li Z, Zhan W, Wang Z, Zhu B, He Y, Peng J, Cai S, Ma J.
Biochem Biophys Res Commun. 2006 Sep 15;348(1):229-37.
A limited set of human MicroRNA is deregulated in follicular thyroid carcinoma.
Weber F, Teresi RE, Broelsch CE, Frilling A, Eng C.
J Clin Endocrinol Metab. 2006 Sep;91(9):3584-91.
Augmentation of tumor angiogenesis by a Myc-activated microRNA cluster.
Dews M, Homayouni A, Yu D, Murphy D, Sevignani C, Wentzel E, Furth EE, Lee WM, Enders GH, Mendell JT, Thomas-Tikhonenko A.
Nat Genet. 2006 Sep;38(9):1060-5.
Somatic stem cells and the origin of cancer.
Martinez-Climent JA, Andreu EJ, Prosper F.
Clin Transl Oncol. 2006 Sep;8(9):647-63.
The Hippo pathway regulates the bantam microRNA to control cell proliferation and apoptosis in Drosophila.
Thompson BJ, Cohen SM.
Cell. 2006 Aug 25;126(4):767-74.
MicroRNA-cancer connection: the beginning of a new tale.
Calin GA, Croce CM.
Cancer Res. 2006 Aug 1;66(15):7390-4.
[Progress on the research of microRNA and its functions in lymphoid malignancies--review]
Xu W, Li JY, Lu FX.
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2006 Aug;14(4):840-4.
Chromosomal translocations fusing the BCL6 gene to different partner loci are recurrent in primary central nervous system lymphoma and
may be associated with aberrant somatic hypermutation or defective class switch recombination.
Schwindt H, Akasaka T, Zuhlke-Jenisch R, Hans V, Schaller C, Klapper W, Dyer MJ, Siebert R, Deckert M.
J Neuropathol Exp Neurol. 2006 Aug;65(8):776-82.
MicroRNA: biogenetic and functional mechanisms and involvements in cell differentiation and cancer.
Tsuchiya S, Okuno Y, Tsujimoto G.
J Pharmacol Sci. 2006 Aug;101(4):267-70.
MicroRNAs in leukemia.
Croce C.
Clin Adv Hematol Oncol. 2006 Aug;4(8):577-8.
Identification by Real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues.
Bandres E, Cubedo E, Agirre X, Malumbres R, Zarate R, Ramirez N, Abajo A, Navarro A, Moreno I, Monzo M, Garcia-Foncillas J.
Mol Cancer. 2006 Jul 19;5:29.
No miR hype: microRNA's cancer role expands.
Garber K.
J Natl Cancer Inst. 2006 Jul 5;98(13):885-7.
[Research progress in cancer genomics]
Fang FD.
Zhonghua Zhong Liu Za Zhi. 2006 Jul;28(7):555-7.
Optimized high-throughput microRNA expression profiling provides novel biomarker assessment of clinical prostate and breast cancer
biopsies.
Mattie MD, Benz CC, Bowers J, Sensinger K, Wong L, Scott GK, Fedele V, Ginzinger D, Getts R, Haqq C.
Mol Cancer. 2006 Jun 19;5:24.
microRNAs exhibit high frequency genomic alterations in human cancer.
Zhang L, Huang J, Yang N, Greshock J, Megraw MS, Giannakakis A, Liang S, Naylor TL, Barchetti A, Ward MR, Yao G, Medina A,
O'brien-Jenkins A, Katsaros D, Hatzigeorgiou A, Gimotty PA, Weber BL, Coukos G.
Proc Natl Acad Sci U S A. 2006 Jun 13;103(24):9136-41.
MicroRNAs and leukemias: how strong is the connection?
Calin GA, Garzon R, Cimmino A, Fabbri M, Croce CM.
Leuk Res. 2006 Jun;30(6):653-5.
MicroRNA deregulation in human thyroid papillary carcinomas.
Pallante P, Visone R, Ferracin M, Ferraro A, Berlingieri MT, Troncone G, Chiappetta G, Liu CG, Santoro M, Negrini M, Croce CM, Fusco
A.
Endocr Relat Cancer. 2006 Jun;13(2):497-508.
MicroRNA trafficking and human cancer.
Yue J, Tigyi G.
Cancer Biol Ther. 2006 Jun;5(6):573-8.
Involvement of human micro-RNA in growth and response to chemotherapy in human cholangiocarcinoma cell lines.
Meng F, Henson R, Lang M, Wehbe H, Maheshwari S, Mendell JT, Jiang J, Schmittgen TD, Patel T.
Gastroenterology. 2006 Jun;130(7):2113-29.
Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells.
Saito Y, Liang G, Egger G, Friedman JM, Chuang JC, Coetzee GA, Jones PA.
Cancer Cell. 2006 Jun;9(6):435-43.
Cancer genomics: the unknown unknowns.
Lotze MT, Yu Y.
Curr Opin Investig Drugs. 2006 Jun;7(6):497-500.
MicroRNAs: small but potent oncogenes or tumor suppressors.
Lee YS, Dutta A.
Curr Opin Investig Drugs. 2006 Jun;7(6):560-4.
MicroRNAs in mammalian development and tumorigenesis.
O'Rourke JR, Swanson MS, Harfe BD.
Birth Defects Res C Embryo Today. 2006 Jun;78(2):172-9.
Pre-B cell proliferation and lymphoblastic leukemia/high-grade lymphoma in E(mu)-miR155 transgenic mice.
Costinean S, Zanesi N, Pekarsky Y, Tili E, Volinia S, Heerema N, Croce CM.
Proc Natl Acad Sci U S A. 2006 May 2;103(18):7024-9.
[Cancer epigenetics]
Si LS.
Zhonghua Bing Li Xue Za Zhi. 2006 May;35(5):302-5.
let-7 microRNA functions as a potential growth suppressor in human colon cancer cells.
Akao Y, Nakagawa Y, Naoe T.
Biol Pharm Bull. 2006 May;29(5):903-6.
Small RNAs and non-small cell lung cancer.
Tong AW.
Curr Mol Med. 2006 May;6(3):339-49.
Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues.
Murakami Y, Yasuda T, Saigo K, Urashima T, Toyoda H, Okanoue T, Shimotohno K.
Oncogene. 2006 Apr 20;25(17):2537-45.
Differentially regulated micro-RNAs and actively translated messenger RNA transcripts by tumor suppressor p53 in colon cancer.
Xi Y, Shalgi R, Fodstad O, Pilpel Y, Ju J.
Clin Cancer Res. 2006 Apr 1;12(7 Pt 1):2014-24.
[Expression of miR-28 in B cell lymphoma cell lines detected by solution hybridization]
Xu W, Li JY, Lu FX.
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2006 Apr;14(2):289-92.
Oncomirs - microRNAs with a role in cancer.
Esquela-Kerscher A, Slack FJ.
Nat Rev Cancer. 2006 Apr;6(4):259-69.
Genomics of chronic lymphocytic leukemia microRNAs as new players with clinical significance.
Calin GA, Croce CM.
Semin Oncol. 2006 Apr;33(2):167-73.
MicroRNAs in cell proliferation, cell death, and tumorigenesis.
Hwang HW, Mendell JT.
Br J Cancer. 2006 Mar 27;94(6):776-80.
A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors.
Voorhoeve PM, le Sage C, Schrier M, Gillis AJ, Stoop H, Nagel R, Liu YP, van Duijse J, Drost J, Griekspoor A, Zlotorynski E, Yabuta N, De
Vita G, Nojima H, Looijenga LH, Agami R.
Cell. 2006 Mar 24;124(6):1169-81.
Molecular profiling of cervical neoplasia.
Martin CM, Astbury K, O'Leary JJ.
Expert Rev Mol Diagn. 2006 Mar;6(2):217-29.
Unique microRNA molecular profiles in lung cancer diagnosis and prognosis.
Yanaihara N, Caplen N, Bowman E, Seike M, Kumamoto K, Yi M, Stephens RM, Okamoto A, Yokota J, Tanaka T, Calin GA, Liu CG,
Croce CM, Harris CC.
Cancer Cell. 2006 Mar;9(3):189-98.
A microRNA expression signature of human solid tumors defines cancer gene targets.
Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, Petrocca F, Visone R, Iorio M, Roldo C, Ferracin M, Prueitt RL, Yanaihara N, Lanza G,
Scarpa A, Vecchione A, Negrini M, Harris CC, Croce CM.
Proc Natl Acad Sci U S A. 2006 Feb 14;103(7):2257-61.
MicroRNA in chronic lymphocytic leukemia.
Borkhardt A, Fuchs U, Tuschl T.
N Engl J Med. 2006 Feb 2;354(5):524-5; author reply 524-5.
MicroRNA in chronic lymphocytic leukemia.
Chng WJ.
N Engl J Med. 2006 Feb 2;354(5):524-5; author reply 524-5.
Lack of BIC and microRNA miR-155 expression in primary cases of Burkitt lymphoma.
Kluiver J, Haralambieva E, de Jong D, Blokzijl T, Jacobs S, Kroesen BJ, Poppema S, van den Berg A.
Genes Chromosomes Cancer. 2006 Feb;45(2):147-53.
miR-155/BIC as an oncogenic microRNA.
Tam W, Dahlberg JE.
Genes Chromosomes Cancer. 2006 Feb;45(2):211-2.
MicroRNAs as oncogenes.
Hammond SM.
Curr Opin Genet Dev. 2006 Feb;16(1):4-9.
MicroRNAs as a potential magic bullet in cancer.
Slack FJ, Weidhaas JB.
Future Oncol. 2006 Feb;2(1):73-82.
Clarifications on miRNA and cancer.
Ruvkun G.
Science. 2006 Jan 6;311(5757):36-7.
Increased expression of microRNA-155 in Epstein-Barr virus transformed lymphoblastoid cell lines.
Jiang J, Lee EJ, Schmittgen TD.
Genes Chromosomes Cancer. 2006 Jan;45(1):103-6.
RNA interference: ready to silence cancer?
Mocellin S, Costa R, Nitti D.
J Mol Med. 2006 Jan;84(1):4-15.
PI3K signaling and miRNA expression during the response of quiescent human fibroblasts to distinct proliferative stimuli.
Gu J, Iyer VR.
Genome Biol. 2006;7(5):R42.
Identifying microRNA regulators of cell death in Drosophila.
Chen CH, Guo M, Hay BA.
Methods Mol Biol. 2006;342:229-40.